SCHEMBL7485392

SCHEMBL7485392

Nc1c(-c2cc(Cl)ccc2O)c2cc(Cl)ccc2[nH]c1=O

nearest known ligand 0.63

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PIM1 P11309 2/20 0.63
CDK2 P24941 2/20 0.63
CLK2 P49760 2/20 0.63
GSK3B P49841 2/20 0.63
CAMK2B Q13554 2/20 0.63
CAMK2G Q13555 2/20 0.63
CAMK2D Q13557 2/20 0.63
DYRK1A Q13627 2/20 0.63
CDC42BPA Q5VT25 2/20 0.63
PLK3 Q9H4B4 2/20 0.63
CLK4 Q9HAZ1 2/20 0.63
STK17A Q9UEE5 2/20 0.63
CSF1R P07333 2/20 0.63
ROCK2 O75116 1/20 0.63
MAP4K4 O95819 1/20 0.63
LCK P06239 1/20 0.63
RPS6KB1 P23443 1/20 0.63
MAPK1 P28482 1/20 0.63
EPHA2 P29317 1/20 0.63
FLT3 P36888 1/20 0.63

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8477008 0.91 GSK3B (0.53) PIM1CDK2CLK2GSK3BCAMK2B
SCHEMBL8479083 0.89 GSK3B (0.56) PIM1CDK2CLK2GSK3BCAMK2B
SCHEMBL8475930 0.89 GSK3B (0.54) PIM1CDK2CLK2GSK3BCAMK2B
SCHEMBL8479190 0.89 CYP2C9 (0.73) PIM1CDK2CLK2GSK3BCAMK2B
SCHEMBL8479093 0.87 CDK2 (0.52) PIM1CDK2CLK2GSK3BCAMK2B
Formic Acid SCHEMBL8479075 0.85 CYP2C9 (0.68) PIM1CDK2CLK2GSK3BCAMK2B
SCHEMBL8476391 0.82 CYP2C9 (0.53) PIM1CDK2CLK2GSK3BCAMK2B
SCHEMBL8481285 0.82 PIM1 (0.55) PIM1CDK2CLK2GSK3BCAMK2B
SCHEMBL8481050 0.81 PIM1 (0.76) PIM1CDK2CLK2GSK3BCAMK2B
SCHEMBL8480429 0.80 CYP2C9 (0.62) PIM1CDK2CLK2GSK3BCAMK2B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1011677-A4 4-ARYL-3-AMINOQUINOLINE-2-ONE DERIVATIVES AS POTASSIUM CHANNEL MODULATORS BRISTOL MYERS SQUIBB CO (US) 2002-03-20 EP disclosed
EP-1011677-A1 4-ARYL-3-AMINOQUINOLINE-2-ONE DERIVATIVES AS POTASSIUM CHANNEL MODULATORS Bristol-Myers Squibb Company (US) 2000-06-28 EP disclosed
US-5972961-A ANTIISCHEMIC AGENTS; ANTICONVULSANTS; HEADACHES; SEXUAL DISORDERS BRISTOL-MYERS SQUIBB COMPANY (US) 1999-10-26 US disclosed
WO-1999009983-A1 4-ARYL-3-AMINOQUINOLINE-2-ONE DERIVATIVES AS POTASSIUM CHANNEL MODULATORS BRISTOL-MYERS SQUIBB COMPANY (US) 1999-03-04 WO disclosed